SÖZ
ALTI
NEWS
Home
The day in news
This week
Archive
Crisis
About
EN
AZ
sözaltı
news
Finance
Finance
EN
AZ
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
finance.yahoo.com
08.09.2026 19:08
5 views
Copy link
Save
Pick
Copy link
WhatsApp
Telegram
X
Reddit
Facebook
LinkedIn
Email
More
Image
Share image
Save
Copy link
Similar stories
1 outlet
Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff
marketwatch.com
08.09.2026
Related stories
Tung Chee-hwa, Hong Kong chief executive, 1937-2026
ft.com · 08.09
Meta unveils AI personal assistant linked to WhatsApp and Instagram
ft.com · 08.09
Stocks are stumbling after Labor Day. Why the easy gains of 2026 may be over.
marketwatch.com · 08.09
Why a stronger Japanese currency could spell trouble for AI and technology stocks
marketwatch.com · 08.09
Smithsonian head to resign as Trump seeks to reshape institution
ft.com · 08.09
Why you shouldn’t stake your entire retirement plan on getting an inheritance
marketwatch.com · 08.09
← Previous
Bitcoin analyst spots 2015 signal that preceded 9,800% rally
Next →
Prediction: This ETF Will Beat the SPY Through 2027 (Not the QQQ!)